Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Semin Nurse Manag ; 6(2): 69-74, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9653365

ABSTRACT

This article chronicles the barriers encountered as a multidisciplinary department undertook management restructuring. Barriers that are addressed include lack of a sense of urgency; confusion and fear regarding the changing roles of both staff and managers; insufficient development of coaching skills; and lack of alignment of performance appraisals, outcomes, and rewards. Insights gained and strategies to deal with these barriers are discussed.


Subject(s)
Hospital Restructuring/organization & administration , Nursing, Supervisory/organization & administration , Patient Care Team/organization & administration , Quality Assurance, Health Care/organization & administration , Attitude of Health Personnel , Health Knowledge, Attitudes, Practice , Humans , Job Description , Nursing Staff, Hospital/organization & administration , Nursing Staff, Hospital/psychology , Organizational Innovation , Program Evaluation , Quality of Health Care
2.
J Pathol ; 180(3): 259-65, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8958802

ABSTRACT

The development of colorectal carcinoma from adenomas is recognized as the dominant mechanism of colon carcinogenesis. However, early colon carcinomas are being increasingly detected which have no adenomatous elements in their vicinity, and which, despite their small size, already show submucosal invasion. Such tumours (so-called 'de novo' carcinomas) have renewed consideration of the de novo colorectal carcinogenesis pathway. The goal of this study was to evaluate the expression of tumour suppressor gene p53 and apoptosis control gene bcl-2 in de novo carcinomas, compared with early carcinomas developing in the background of an adenoma (ex-adenoma). Fifty cases each of de novo and ex-adenoma carcinomas (pT1) were studied. p53 expression was significantly higher in the de novo carcinomas than in the ex-adenoma carcinomas (62 per cent vs. 42 per cent), while bcl-2 tended to be weaker in the de novo than in the ex-adenoma carcinomas. These differences' support the concept that de novo carcinomas are a unique pathological entity, with a phenotype reflecting their more aggressive behaviour.


Subject(s)
Adenocarcinoma/metabolism , Adenoma/metabolism , Colonic Neoplasms/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Tumor Suppressor Protein p53/metabolism , Adenocarcinoma/pathology , Adenoma/pathology , Adult , Aged , Aged, 80 and over , Colonic Neoplasms/pathology , Disease Progression , Female , Humans , Immunoenzyme Techniques , Male , Middle Aged , Neoplasm Proteins/metabolism , Rectal Neoplasms/metabolism , Rectal Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...